Body Fat Distribution Affects Risk of Prostate Cancer

There is "strong evidence" as classified by the World Cancer Research Fund that obesity is associated with an increased risk of prostate cancer. In order to investigate this further, researchers objectively measured body fat distribution of men and their risk of developing prostate cancer. For this study, called the Age, Gene/Environment Susceptibility-Reykjavik study, results of which were published in Cancer , 1,832 men went through baseline computed tomography (CT) imaging of fat deposition, ...
Continue reading

Prostate Cancer: Adding Enzalutamide to First-Line Therapy

With around 170,000 men in the United States projected to be diagnosed with prostate cancer this year, it is the most common cancer in men. Androgen therapy is usually administered for progressive disease; however, hormone-sensitive prostate cancer can develop into castration-resistant prostate cancer, signifying treatment resistance to androgen deprivation therapy or to antiandrogens. There is a lack of understanding surrounding the transition from castration-sensitive to castration-resistant a...
Continue reading

Avoiding Narcotics in Post-Surgery Cancer Pain Management

​ Opioid addiction, which is currently so widespread that it amounts to a national crisis, often starts with the legitimate use of prescription pain medication after surgery or as a result of another medical condition. For this reason, it is essential to develop non-narcotic strategies to handle pain. A team of researchers in the Perelman School of Medicine at the University of Pennsylvania did just that, designing a program that successfully managed post-surgery pain for patients with urol...
Continue reading

Patients with Prostate Cancer: Is Testosterone Treatment OK?

In this Q&A session at the Oncology Nursing Society (ONS) 44th Annual Congress in Anaheim, California, Kathleen Burns, MSN, ANP, OCN®, addresses whether low-risk patients with prostate cancer can receive testosterone. What are your thoughts on initiating testosterone treatments for men who are low risk, have received some type of treatment, either castration or radiation, but can't handle the low testosterone? Kathleen D. Burns, MSN, ANP, OCN®: We recently completed a clinical trial where we...
Continue reading

An Alternative to Biopsy: Improved CTC Collection Method

​ Researchers at the University of Michigan have developed a prototype of a wearable device that can continuously collect circulating tumor cells (CTCs) directly from a patient's bloodstream. The investigators hope that this device, which has thus far proven successful in canine models, could ultimately be used as an alternative to biopsies. Circulating tumor cells, which circulate through lymphatic channels and blood after they are shed from the primary tumor, are the basis for cancer metastase...
Continue reading

© Copyright 2019 i3 Health. All rights reserved.